超声引导下经皮射频消融治疗黏膜下子宫肌瘤的有效性和安全性

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (644 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the efficacy and safety of ultrasound-guided percutaneous radiofrequency ablation for submucous uterine fibroids. Methods A retrospective study of 78 patients with symptomatic submucosal uterine fibroids who were treated between March 2016 and November 2017 and met the inclusion criteria was performed to calculate the complete ablation rate of uterine fibroids. The results were compared and the uterus was compared 3 months after ablation,so were fibroid volume, hemoglobin (Hb) quantification, uterine fibroid symptoms and health-related quality of life questionnaire (UFS-QOL) scores. Adverse reactions and complications were recorded during the course of treatment and follow-up.Results The volume reduction rates of lesions at 3, 6, 9, and 12 months after radiofrequency ablation were 65.3%, 75.6%, 81.5%, and 91.6%, respectively. The volume of uterine fibroids, hemoglobin and UFS-QOL scores were significantly decreased at 3 months after treatment (P<0.01). No serious complications were found three days after ablation.Conclusions Ultrasound-guided percutaneous radiofrequency ablation is a safe and effective treatment for submucosal uterine fibroids,which is suitable for patients with uterus retention.

Key words： uterine fibroids radiofrequency ablation hemoglobin UFS-QOL score ultrasound-guided

Received: 20 April 2019

ZTFLH:

R540.4

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	CHEN Baohua
	GUI Xiongjian
	MAO Ying
	WANG Jianrong
	and MIU Jiulin

Cite this article:

CHEN Baohua,GUI Xiongjian,MAO Ying等. Clinical value of ultrasound-guided radiofrequency ablation for submucous uterine fibroids[J]. Med. J. Chin. Peop. Armed Poli. Forc., 2019, 30(10): 870-872.

URL:

http://journal08.magtechjournal.com/Jwk_wjyx/EN/ OR http://journal08.magtechjournal.com/Jwk_wjyx/EN/Y2019/V30/I10/870

[1]	董欣, 杨威威, 刘晓艳. 子宫肌瘤不同手术方式对卵巢与性功能的影响[J]. 武警医学, 2017,28(2):145-146.
[2]	袁珍. 子宫肌瘤患者三种不同术式对卵巢功能的影响[D]. 南昌:南昌大学医学院, 2013.
[3]	胡美丽,王雅慧,杨欣,等.高强度聚焦超声消融治疗子宫肌瘤疗效观察[J]. 武警医学, 2015, 26(11):1115-1117.
[4]	Chen I, Firth B, Hopkins L, et al. Clinical characteristics differentiating uterine sarcoma and fibroids[J]. JSLS,2018,22(1):78-82.
[5]	Sohn G S, Cho S, Kim Y M, et al. Current medical treatment of uterine fibroids[J]. Obstet Gynecol Sci, 2018, 61(2): 192-201.
[6]	Turtulici G, Orlandi D, Dedone G, et al. Ultrasound-guided transvaginal radiofrequency ablation of uterine fibroids assisted by virtual needle tracking system: a preliminary study[J]. Int J Hyperthermia,2018,11 : 1-8.
[7]	Lee B B, Yu S P. Radiofrequency ablation of uterine fibroids: a review[J]. Curr Obstet Gynecol Rep,2016,5(4): 318-324.
[8]	Kim C H, Kim S R, Lee H A, et al. Transvaginal ultrasound guided radiofrequency myolysis for uterine myomas[J]. Hum Reprod,2011,26(3): 559-563.
[9]	Spies J B, Coyne K, Guaou G N, et al. The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata[J]. Obstet Gyneco,2002, 99(2): 290-300.
[10]	Brucker S Y, Hahn M, Kraemer D, et al. Laparoscopic radiofrequency volumetric thermal ablation of fibroids versus laparoscopic myomectomy[J]. Int J Gynaecol Obstet,2014,125(3): 261-265.
[11]	Meng X, He G, Zhang J, et al. A comparative study of fibroid ablation rates using radio frequency or high-intensity focused ultrasound[J]. Cardiovasc Intervent Radiol, 2010, 33(4): 794-799.